Cancer, unmet need
Cancer remains a major health issue in the world affecting one third of the population
The unmet need
Understanding factors promoting cancer aggressiveness has the potential of finding new targets and treatments helping to cure cancer.
1/3 gets cancer
Cancer remains a major health issue in the world affecting one third of the population
1/5 dies from Cancer
1/5 affected dies from Cancer
+ 62% Projection to 2030
Projected cancer increase 2018-2030, worldwide
Ex. Breast Cancer
- Most common cancer in women (24%) worldwide
- 2nd most common cancer overall
- 2,09 million new cases diagnosed in 2018
- Represents about 11,6% of all new cancer cases
- Most common cause of death from cancer in women.
Iscaffpharmas technology improves success rate in drug development bringing effective treatments to cancer patients.
(The Global Cancer Observatory, 2018)
Products & Services
Iscaffpharmas deep understanding of the human cancer microenvironment provides unparalleled opportunities for:
-
- Target discovery and drug validation
- Drug screening in patients derived scaffolds (PDS) and synthetic replicas
- Individualized treatment and companion diagnostics
The PDS technology gives access to human relevant models in pre-clinical settings and reduces at the same time unneccesary animal experiments.
- Target discovery and drug validation
- Drug screening in patients derived scaffolds (PDS) and synthetic replicas
- Individualized treatment and companion diagnostics
Development support
Target identification
Screening of NCEs on gene expression and other factors
Used technologies
Synthetic scaffolds
Patient derived scaffolds
Solid tumours
Diagnostics
Precision
Personalized treatment
Liquid biopsy
